Joyance Partners

Joyance Partners is a San Francisco-based venture capital firm dedicated to investing in companies that leverage science and technology to enhance human well-being and cultivate joy. Their core investment thesis, often referred to as the "Human Operating System," centers on improving fundamental aspects of human life. This includes areas such as food and nutrition, health and wellness, mind and body optimization, and personal environment enhancements. The firm seeks out innovative startups that offer solutions designed to make people healthier, happier, and more connected.

Joyance Partners primarily focuses on early-stage investments, typically participating in Seed and Series A rounds. They are known for providing initial capital to promising companies with strong scientific foundations and clear paths to market. According to their stated investment criteria, initial checks range from $500,000 to $1 million, with additional capital reserved for follow-on investments in successful portfolio companies. This strategic approach allows them to support companies from their formative stages through significant growth milestones.

Since its inception, Joyance Partners has raised multiple funds to support its investment strategy. Their first fund, Joyance Partners I, closed at $20 million in 2017, followed by Joyance Partners II, which secured $21.3 million in 2020. Most recently, the firm announced the closing of Joyance Partners III with $30 million in December 2023, demonstrating continued investor confidence in their unique focus. With a portfolio spanning over 100 companies, Joyance Partners has established itself as a significant player in the "joy tech" and human well-being sectors, backing ventures that aim to profoundly improve daily life through technological innovation.